Gadolinium Contrast Media Market

Gadolinium Contrast Media Market contains market size and forecasts of Gadolinium Contrast Media in global, including the following market information:

• Global Gadolinium Contrast Media Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Gadolinium Contrast Media Market Sales, 2017-2022, 2023-2028, (K L)
• Global top five Gadolinium Contrast Media companies in 2021 (%)

The global Gadolinium Contrast Media market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Gadobutrol Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gadolinium Contrast Media include Bayer, Takeda, Fuji Pharma, Towaseiyaku, Hikari Pharmaceutical, BeiLu Pharma, Guerbet, GE and Sanochemia, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Gadolinium Contrast Media manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gadolinium Contrast Media Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K L)

Global Gadolinium Contrast Media Market Segment Percentages, by Type, 2021 (%)

• Gadobutrol
• Gadopentetate Dimeglumine
• Gadoterate Meglumine
• Gadobenate Dimeglumine
• Gadoteridol
• Others

Global Gadolinium Contrast Media Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K L)

Global Gadolinium Contrast Media Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global Gadolinium Contrast Media Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K L)

Global Gadolinium Contrast Media Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Gadolinium Contrast Media revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Gadolinium Contrast Media revenues share in global market, 2021 (%)
• Key companies Gadolinium Contrast Media sales in global market, 2017-2022 (Estimated), (K L)
• Key companies Gadolinium Contrast Media sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• Takeda
• Fuji Pharma
• Towaseiyaku
• Hikari Pharmaceutical
• BeiLu Pharma
• Guerbet
• GE
• Sanochemia
• T2Pharma
• b.e.imaging GmbH
• Hengrui Medicine
• Bracco